Drawing for MEDUZAGEN

USPTO serial 79178890

MEDUZAGEN

Reviewed by CopyMark Law Group

Reg. 5019860Status 404
Filing date
Status date
Registration date
Aug 16, 2016
Examiner
MEYERS, MORGAN LAURA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MEDUZAGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David M. Silverman, Esq.

David M. Silverman, Esq. Davis Wright Tremaine LLP1919 Pennsylvania Ave., N.W.Suite 800Washington, DC 20006-3401

Goods and services

ClassDescriptionStatusFirst use
009Computer software for use in accessing, updating, manipulating, modifying, organizing, storing, backing up, synchronizing, transmitting and sharing data, documents, files, information and multimedia content relating to data in the medical fieldSECTION 71 - CANCELLED—
042Design and development of computer hardware and software; research on the subject of pharmaceuticals; research and development of vaccines and medicines; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical drug development services; drug discovery services; analysis of human serum for medical research; analysis of human tissues for medical research; structural and functional analysis of genomes; computerised analysis of data in the field of medical research; computer assisted analysis services in the field of medical research; chemical research and analysis services; analytical services relating to the assessment of the bacterial content of liquids; analysis and research of industrial fluids; analytical services relating to the testing of the bacterial content of liquids; analytical services relating to the determination of the bacterial content of liquidsSECTION 71 - CANCELLED—
044Analysis of human tissues for medical treatment by medical screening; medical screening relating to the heart; genetic testing for medical purposes; medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; analysis of human serum for medical treatmentSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 14, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
May 14, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 27, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Nov 6, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Nov 6, 2023INPCINVALIDATION PROCESSED—
Nov 3, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 3, 2023C71TCANCELLED SECTION 71—
Oct 28, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 16, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 20, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 7, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 17, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 27, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 27, 2017FIMPFINAL DISPOSITION PROCESSED—
Nov 16, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 16, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 31, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 31, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 11, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 25, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 23, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 18, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 18, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 8, 2016ALIEASSIGNED TO LIE—
Mar 29, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 11, 2016RFNTREFUSAL PROCESSED BY IB—
Feb 19, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 19, 2016RFRRREFUSAL PROCESSED BY MPU—
Feb 19, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 18, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2016DOCKASSIGNED TO EXAMINER—
Jan 1, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 28, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 17, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance